Have a feature idea you'd love to see implemented?
Let us know!
TNYA Tenaya Therapeutics Inc
Price (delayed)
$2.16
Market cap
$171.12M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.44
Enterprise value
$177.42M
Highlights
The EPS has increased by 22% year-on-year and by 6% since the previous quarter
The net income is up by 8% year-on-year and by 2.9% since the previous quarter
The debt has grown by 21% year-on-year but it has declined by 7% since the previous quarter
TNYA's equity is down by 32% YoY and by 16% from the previous quarter
The quick ratio is down by 22% YoY and by 17% QoQ
Key stats
What are the main financial stats of TNYA
Market
Valuations
Earnings
Shares outstanding
79.22M
Market cap
$171.12M
Enterprise value
$177.42M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.51
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$117.23M
EBITDA
-$105.21M
Free cash flow
-$95.25M
Per share
Balance sheet
Liquidity
EPS
-$1.44
Free cash flow per share
-$1.11
Book value per share
$1.43
Revenue per share
$0
TBVPS
$1.63
Total assets
$140.58M
Total liabilities
$27.98M
Debt
$14.54M
Equity
$112.6M
Working capital
$69.15M
Debt to equity
0.13
Current ratio
5.27
Quick ratio
4.91
Net debt/EBITDA
-0.06
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-71.1%
Return on equity
-86.2%
Return on invested capital
-100.4%
Return on capital employed
-94.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TNYA stock price
How has the Tenaya Therapeutics stock price performed over time
Intraday
-2.7%
1 week
6.93%
1 month
12.5%
1 year
19.34%
YTD
-33.33%
QTD
11.92%
Financial performance
How have Tenaya Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$122.74M
Net income
-$117.23M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 9% year-on-year and by 3.3% since the previous quarter
The net income is up by 8% year-on-year and by 2.9% since the previous quarter
Growth
What is Tenaya Therapeutics's growth rate over time
Valuation
What is Tenaya Therapeutics stock price valuation
P/E
N/A
P/B
1.51
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 22% year-on-year and by 6% since the previous quarter
TNYA's equity is down by 32% YoY and by 16% from the previous quarter
TNYA's P/B is 16% below its last 4 quarters average of 1.8
Efficiency
How efficient is Tenaya Therapeutics business performance
Tenaya Therapeutics's return on equity has decreased by 37% YoY and by 6% QoQ
The ROA has contracted by 31% YoY and by 4.9% from the previous quarter
TNYA's ROIC is down by 15% YoY but it is up by 8% QoQ
Dividends
What is TNYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TNYA.
Financial health
How did Tenaya Therapeutics financials performed over time
Tenaya Therapeutics's total assets has decreased by 27% YoY and by 14% from the previous quarter
The quick ratio is down by 22% YoY and by 17% QoQ
The debt is 87% smaller than the equity
TNYA's debt to equity has surged by 86% year-on-year and by 8% since the previous quarter
TNYA's equity is down by 32% YoY and by 16% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.